Description of Baseline Characteristics of Pediatric Allergic Asthma Patients Including those Initiated on Omalizumab

BACKGROUND: Indication of omalizumab in the United States was recently extended to include pediatric (6–11 years) uncontrolled moderate-to-severe allergic asthma patients. OBJECTIVE: The purpose of this study was to describe baseline characteristics of this population from a real-world dataset. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavati, Abhishek, Pilon, Dominic, Ortiz, Benjamin, Paknis, Brandee, Vegesna, Ashok, Schiffman, Bradd, Zhdanava, Maryia, Lefebvre, Patrick, Stone, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028162/
https://www.ncbi.nlm.nih.gov/pubmed/29977648
http://dx.doi.org/10.1177/2152656718763387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028162/
https://www.ncbi.nlm.nih.gov/pubmed/29977648
http://dx.doi.org/10.1177/2152656718763387

Ejemplares similares